LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care.
With most of its products indicated for serious and rare diseases, LFB is a major player in this area.
The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies.
With a sustained investment in research and development, the LFB Group bases its strategy on its international deployment and the design of innovative therapies.
Company Details
- Employees
- 2.56K
- Founded
- -
- Address
- 3 Avenue Des Tropiques - Bp 305 Les Ulis - Zone D'activités De Courtaboeuf, Les Ulis,france 91940,france
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- lfb.fr
- HQ
- Les Ulis, France
Lfb Questions
Lfb's website is lfb.fr
Lfb's LinkedIn profile is https://fr.linkedin.com/company/lfb
Lfb has
2.56K employees.
View email and phone details for 2.56K
employees at Lfb.
Lfb's industry is
Pharmaceutical Manufacturing
Lfb's top competitors are
Pierre Fabre Laboratories,
Sanofi,
Ipsen,
Lfb Biomanufacturing,
Novo Nordisk,
Gsk,
Novartis,
Servier,
Stallergenes Greer,
Biogaran.
Lfb's categories are Pharmaceutical Manufacturing
Lfb's founding year is 1994
